Article metrics

Download PDFPDF

748 Phase 1/2 study of the hexavalent OX40 agonist INBRX-106 alone and in combination with pembrolizumab in select solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023238019
Dec 20237209
Jan 20243303
Feb 20248408
Mar 202414608
Apr 2024130010
May 202486020
Jun 202495010
Jul 20248606
Aug 2024122013
Sep 2024161015
Oct 2024186012
Nov 2024178013
Dec 2024133017
Jan 2025180014
Feb 202575016
Mar 20250010
Apr 2025009
May 2025006
Jun 2025106
Total20060224